(Shanghai, January 20, 2022)— Dr. Junbo Wang & his team from BioDuro-Sundia’s Chemistry department won the ” Best Collaboration Award ” issued by Luye Pharma, in recognition of their great contribution for drug chemistry discovery projects in 2021.
Dr. Liang Ye, Head of the Drug Discovery R&D Department of Luye Pharma, fully affirmed the work of Dr. Junbo Wang’s team in 2021. He said, “The BioDuro-Sundia team handled the project meticulously, actively addressed our needs, and completed the project with high quality. I am full of expectations for the future cooperation between the two companies.” Dr. Junbo Wang, senior director of Shanghai Chemistry Department, expressed his sincere gratitude to Luye Pharma and praised the hard work of the entire team. “We are honored to be Luye Pharma’s partner to promote the development process of innovative drug projects. Customer first is the belief BioDuro-Sundia always adhered to. With our experienced chemists team, we spare no efforts to complete the development of more effective compounds for customers, and accelerate the progress to pre-clinical stage as soon as possible. We wish Luye Pharma to develop more innovative therapies to benefit patients around the world!”
BioDuro-Sundia Chemistry Department currently has R&D sites in Shanghai, Wuxi, Shijiazhuang, Beijing and Taiwan, with a team of more than 1,350 experienced scientists, of which over 52% possess post-graduate degrees. Capitalizing on its experienced scientists and state of the art facilities, BioDuro-Sundia provides services to over 330 pharmaceutical and biotechnology companies globally. At present, the chemical team possesses extensive expertise across the fields of medicinal chemistry, computational chemistry, parallel synthesis, chemical synthesis, analytical chemistry and scale-up, providing integrated chemical synthesis services from target discovery to lead compound optimization.
About Luye Pharma
Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.
BioDuro-Sundia, an Advent International portfolio company, is a leading contract research, development and manufacturing organization (CRDMO) that provides biopharmaceutical partners with fully integrated services to support drug discovery, development and manufacturing for both drug substance and drug product – from discovery to commercialization. The company is the industry’s third largest, with major operations in China and the US—featuring more than 2,500 employees and 10 global sites.